Cargando…
Combination drug regimens for metastatic clear cell renal cell carcinoma
Renal cell carcinomas (RCC) make up about 90% of kidney cancers, of which 80% are of the clear cell subtype. About 20% of patients are already metastatic at the time of diagnosis. Initial treatment is often cytoreductive nephrectomy, but systemic therapy is required for advanced RCC. Single agent ta...
Autores principales: | Khetani, Viraj V, Portal, Daniella E, Shah, Mansi R, Mayer, Tina, Singer, Eric A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443831/ https://www.ncbi.nlm.nih.gov/pubmed/32879843 http://dx.doi.org/10.5306/wjco.v11.i8.541 |
Ejemplares similares
-
Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging Malignancy
por: Drobner, Jake, et al.
Publicado: (2023) -
Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015) -
Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
por: Vecchio, Sharon J. Del, et al.
Publicado: (2018) -
Metastatic clear cell variant of renal cell carcinoma of the mandible: Review and case report
por: Shah, Ajaz, et al.
Publicado: (2016) -
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
por: Vano, Yann-Alexandre, et al.
Publicado: (2021)